These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424 [TBL] [Abstract][Full Text] [Related]
5. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650 [TBL] [Abstract][Full Text] [Related]
6. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Misthos P; Sepsas E; Athanassiadi K; Kakaris S; Skottis I Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262 [TBL] [Abstract][Full Text] [Related]
7. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275 [TBL] [Abstract][Full Text] [Related]
9. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138 [TBL] [Abstract][Full Text] [Related]
10. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer. Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135 [TBL] [Abstract][Full Text] [Related]
11. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813 [TBL] [Abstract][Full Text] [Related]
12. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761 [TBL] [Abstract][Full Text] [Related]
13. [Skip metastasis to mediastinal lymph nodes: clinical significance and prognosis in stage III non-small cell lung cancer]. Chen QK; Ding JA; Gao W; Zhu YM Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):472-4. PubMed ID: 16115397 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Casali C; Stefani A; Natali P; Rossi G; Morandi U Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734 [TBL] [Abstract][Full Text] [Related]
16. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH; J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193 [TBL] [Abstract][Full Text] [Related]
19. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Yoshino I; Yokoyama H; Yano T; Ueda T; Takai E; Mizutani K; Asoh H; Ichinose Y Ann Thorac Surg; 1996 Oct; 62(4):1021-5. PubMed ID: 8823083 [TBL] [Abstract][Full Text] [Related]
20. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]